Curr Opin Biotechnol December 2022 PMID 36332340

Upstream continuous processing: recent advances in production of biopharmaceuticals and challenges in manufacturing.

Cary Matanguihan, Paul Wu

Mentions

6
Peak: 2 in Oct 2025
across 3 sources since Sep 2025

Extended reach

432
potential audience

Total likes

1

Video views

287

Mentions per month

Sep 2025 – Nov 2025

Where it's discussed

  • X / Twitter2 posts
  • YouTube2 videos
  • News2 articles

AI synopsis

What people are saying

We're still gathering social media discussions on this article. A synopsis appears once there are enough posts to summarize.

AgreementNeither agree nor disagree
InterestNeutral interest
EngagementNeutral engagement
ImpactNeutral impact

Abstract in brief

  • Recent advances in upstream continuous processing focus on improving the production of biopharmaceuticals like therapeutic proteins, viral vectors, and cell therapies through techniques such as perfusion, which involves maintaining high cell densities in bioreactors.
  • Innovations include optimizing operation strategies, enhancing cell density control with feed solutions, and integrating advanced monitoring tools like capacitance sensors and Raman spectroscopy to improve process efficiency and product quality.
  • These developments are not only applied to primary production but also extend to other upstream processes like cell bank preparation and seed bioreactor operations, aiming to make biopharmaceutical manufacturing more continuous, efficient, and scalable.]

Top posts

Most liked on X and Bluesky
CHO Cell Papers
@CHOculturePaper · X

Nov 24, 2025 · 63 followers View post →
CHO Cell Papers
@CHOculturePaper · X

Oct 2, 2025 · 63 followers View post →

All mentions

CHO Cell Papers
@CHOculturePaper · X

Nov 24, 2025 · 63 followers View post →
CHO Cell Papers
@CHOculturePaper · X

Oct 2, 2025 · 63 followers View post →
1 s2.0 S0958166922001628 Main | PDF | Biopharmaceutical | Viral ...
News

https://doi.org/10.1016/j.copbio.2022.102828 stream perfusion process [11] and traced historical progression from the early chemostat process to current

Dec 21, 2025 View →
06 Maximizing Yield of Perfusion Cell Culture Processes Evaluation ...
News

... 10.1016/j. [17] D. Voisard, F. Meuwly, P.A. Ruffieux, G. Baer, A. Kadouri ... 91 (1991), https://doi.org/10.1016/C2013-0- copbio.2022.102828. 04523-9 ...

Dec 21, 2025 View →